# Linperlisib Combined With Chidamide in Patients With PTCL

> **NCT06421948** · PHASE1,PHASE2 · RECRUITING · sponsor: **Yanyan Liu** · enrollment: 134 (estimated)

## Conditions studied

- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** Linperlisib and chidamide
- **DRUG:** Linperlisib and chidamide
- **DRUG:** Linperlisib and chidamide
- **DRUG:** cyclophosphamide, doxorubicin/epirubicin, vincristine, and prednisone

## Key facts

- **NCT ID:** NCT06421948
- **Lead sponsor:** Yanyan Liu
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-25
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06421948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06421948, "Linperlisib Combined With Chidamide in Patients With PTCL". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06421948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*